Clinical Trials Directory

Trials / Completed

CompletedNCT06044610

Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

Utility of Transdermal Optical Imaging TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
PepsiCo Global R&D · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydration or ad libitum fluid intake (GENPOP), 2) an exercise study in moderately active participants in both dehydrated and euhydrated states (EXERCISE). TOI data will be collected alongside standard reference measures of hydration status. This is an exploratory pilot proof of concept study with each subject serving as their own control.

Conditions

Interventions

TypeNameDescription
OTHERGENPOP Passive dehydration (75% reduction in fluid intakeOver 24-hours
OTHERGENPOP Ad lib fluid intakeOver 24 hours
OTHEREXERCISE without fluid replacement90-min standard cycling exercise trial in heat chamber
OTHEREXERCISE with fluid replacement90-min standard cycling exercise trial in heat chamber

Timeline

Start date
2023-05-08
Primary completion
2023-11-15
Completion
2023-11-15
First posted
2023-09-21
Last updated
2024-01-19

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06044610. Inclusion in this directory is not an endorsement.